Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

0.84
Delayed Data
As of 3:59pm ET
 -0.06 / -6.67%
Today’s Change
0.51
Today|||52-Week Range
3.72
+20.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues699.0K69.0K1.1M1.7M
 
 
 
 
 
Cost of Goods Sold119.0K------
 
 
Depreciation And Amortization241.0K60.0K70.0K174.0K
 
 
 
 
 
 
Operating ExpensesGross Income339.0K------
 
 
General Expenses16.7M15.1M19.0M24.0M
 
 
 
 
 
Research And Development9.2M6.6M11.3M18.1M
 
 
 
 
 
Total Operating Expenses17.1M15.2M19.1M24.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.4M-15.1M-18.0M-22.4M
 
 
 
 
 
Extraordinary Credit629.0K28.0K570.0K--
 
 
 
 
Extraordinary Charge-20.0K0.000.00-322.0K
 
 
 
Other Expenses-74.0K-54.0K5.5M104.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.8M-15.1M-11.9M-22.6M
 
 
 
 
 
Income Taxes-565.0K-1.4M-1.7M-3.2M
 
 
 
 
 
Preferred Dividend-728.0K-728.0K-9.3M-200.0K
 
 
 
 
 
Discontinued Operations0.00570.0K57.0K19.0K
 
 
 
 
Net Income-15.2M-13.2M-10.2M-19.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.2M8.3M15.2M22.0M
 
 
 
 
 
Shares To Calculate EPS Diluted7.2M8.3M15.2M22.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.24-$1.68-$1.28-$0.89
 
 
 
 
 
EPS Diluted-$2.24-$1.68-$1.28-$0.89
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account